LGALS3 and head and neck carcinoma: Elevated serum levels of Gal3 have been detected during the progression of various head and neck carcinomas, as well as in acute inflammation and renal failure (Nishiyama et al., 2000; Saussez et al., 2008; Henderson and Sethi, 2009).